EFFECTIVENESS AND SAFETY OF FIRST-LINE BEVACIZUMAB PLUS FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)

被引：0
|
作者：
Pinto, Ana Catarina [1 ]
Teixeira, Margarida [1 ]
Bonito, Nuno [1 ]
Jacinto, Paula [1 ]
Ribeiro, Joao [1 ]
Gervasio, Helena [1 ]
机构：
[1] EPE Coimbra, Med Oncol Serv, Portuguese Inst Oncol Francisco Gentil, Coimbra, Portugal
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v98 / v98
页数：1
相关论文
共 50 条
  • [21] Evaluation of panitumumab (pmab) plus fluorouracil, leucovorin, and irinotecan (FOLFIRI) after first-line bevacizumab (bev) in patients (pts) with metastatic colorectal cancer (mCRC): A subgroup analysis of study 181
    Peeters, M.
    Price, T. J.
    Strickland, A. H.
    Ciuleanu, T. E.
    Scheithauer, W.
    O'Reilly, S.
    Keane, M. M.
    Spigel, D. R.
    Tian, Y.
    Krishnan, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Efficacy and safety of fruquintinib plus mFOLFOX6/FOLFIRI as first-line therapy in advanced metastatic colorectal cancer (mCRC).
    Zhou, Fuxiang
    Wang Wen-bo
    Xia, Ling
    Dai, Jing
    Wu, Han
    Yang, Lei
    Xiong, Zhiguo
    Gong, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 152 - 152
  • [23] Liver and/or lung metastasectomy after cetuximab or bevacizumab plus FOLFIRI chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC).
    Kim, Sang-A
    Kim, Ji-Won
    Suh, Koung Jin
    Kim, Jin Won
    Oh, Heung-Kwon
    Cho, Jai Young
    Kim, Duck-Woo
    Lee, Keun-Wook
    Cho, Sukki
    Kim, Jee Hyun
    Kim, Kwhanmien
    Kang, Sung-Bum
    Jheon, Sanghoon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] CCL2 polymorphism as a predictive marker for bevacizumab (Bev) hi combination with FOLFIRI as first-line treatment in metastatic colorectal cancer (mCRC) patients (pts)
    Siamak, Saadat
    Sunakawa, Yu
    Loupakis, Fotios
    Yang, Dongyun
    Zhang, Wu
    Ning, Yan
    Stintzing, Sebastian
    Stremitzer, Stefan
    Seblo, Ana
    Yamauchi, Shinichi
    Matsusaka, Satoshi
    El-Khoueiry, Rita Elie
    Antoniotti, Carlotta
    Rossini, Daniele
    Cremolini, Chiara
    Falcone, Alfredo
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Clinical and Cost Effectiveness of Bevacizumab plus FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea
    Lee, Eui-Kyung
    Revil, Cedric
    Ngoh, Charles A.
    Lister, Johanna
    Kwon, Jeong-Mi
    Park, Mee-Hye
    Park, Seok-Jin
    Park, Young-Suk
    Shin, Sang-Joon
    Lee, Myung-Ah
    Lee, Nam-Su
    Zang, Dae-Young
    Bae, Eun-Jin
    Kang, Mi-Jeong
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (06) : 1408 - 1419
  • [26] Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions
    Uygun, Kazim
    Bilici, Ahmet
    Kaya, Serap
    Ustaalioglu, Bala Basak Oven
    Yildiz, Ramazan
    Temiz, Suleyman
    Seker, Mesut
    Aksu, Gorkem
    Cabuk, Devrim
    Gumus, Mahmut
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2283 - 2288
  • [27] FOLFIRI VS FOLFIRI plus BEVACIZUMAB IN FIRST-LINE THERAPY OF METASTATIC COLORECTAL CANCER: RETROSPECTIVE ANALYSIS OF 81 PATIENTS IN OUR INSTITUTION
    Rakusic, Z.
    Jajac, L.
    Juretic, A.
    Bisof, V.
    Misir-Krpan, A.
    Santek, F.
    Basic-Koretic, M.
    Plestina, S.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 217 - 217
  • [28] PRELIMINARY EFFICACY, SAFETY AND OPERABILITY OF BEVACIZUMAB(BV) PLUS CAPECITABINE PLUS OXALIPLATIN (XELOX) AS FIRST-LINE THERAPY IN JAPANESE PATIENTS (PTS) WITH INITIALLY UNRESECTABLE METASTATIC COLORECTAL CANCER (MCRC)
    Yamaguchi, K.
    Boku, N.
    Kato, K.
    Komatsu, Y.
    Muro, K.
    Hamamoto, Y.
    Sato, A.
    Koizumi, W.
    Mizunuma, N.
    Takiuchi, H.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 130 - 130
  • [29] Amphiregulin (AREG) expression and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
    Kohne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Twomey, Brian
    Oliner, Kelly Smith
    Boedigheimer, Michael
    Terwey, Jan-Henrik
    Karthaus, Meinolf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) plus FOLFIRI in metastatic colorectal cancer (mCRC).
    Kohne, Claus-Henning
    Hofheinz, Ralf D.
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Twomey, Brian
    Oliner, Kelly Smith
    Boedigheimer, Michael
    Terwey, Jan-Henrik
    Karthaus, Meinolf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345